Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
35
PSTV
Plus Therapeutics
Last Price:
1.26
Seasonality Move:
1.66%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing selling pressure, which indicates risk of future bearish movement.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.3 | Sell |
20-day SMA: | 1.34 | Sell |
50-day SMA: | 1.4 | Sell |
200-day SMA: | 1.72 | Sell |
8-day EMA: | 1.29 | Sell |
20-day EMA: | 1.33 | Sell |
50-day EMA: | 1.4 | Sell |
200-day EMA: | 1.76 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 43.13 | Sell |
Chaikin Money Flow: | -55507 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 1.41) | Sell |
Bollinger Bands (100): | (1.32 - 1.68) | Sell |
Plus Therapeutics Technical Analysis
Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.26 while PSTV 8-day simple moving average is 1.30, which is a Sell signal.
- The stock price of PSTV is 1.26 while Plus Therapeutics 20-day SMA is 1.34, which makes it a Sell.
- Plus Therapeutics 50-day simple moving average is 1.40 while PSTV share price is 1.26, making it a Sell technically.
- PSTV stock price is 1.26 and Plus Therapeutics 200-day simple moving average is 1.72, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.26. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
7.43M
Price in USD:
1.26
Share Volume:
80.18K
Plus Therapeutics 52-Week Range
52-Week High:
2.78
52-Week Low:
1.15
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.26 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.26 while PSTV 8-day exponential moving average is 1.29, which is a Sell signal.
- The stock price of PSTV is 1.26 while Plus Therapeutics 20-day EMA is 1.33, which makes it a Sell.
- Plus Therapeutics 50-day exponential moving average is 1.40 while PSTV share price is 1.26, making it a Sell technically.
- PSTV stock price is 1.26 and Plus Therapeutics 200-day simple moving average is 1.76, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Plus Therapeutics is a Sell
- Plus Therapeutics Relative Strength Index (RSI) is 43.13, which suggest Plus Therapeutics is oversold
- The Bollinger Bands (25) for Plus Therapeutics is (1.29 - 1.41), which suggest Plus Therapeutics is a Sell
- The Bollinger Bands (100) for Plus Therapeutics is (1.32 - 1.68), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.